Baseline CTC count can guide first-line treatment in HR-positive/HER-negative metastatic breast cancer Presented ByProf. François-Clément Bidard, Institut Curie, France TrialPhase 3, STIC CTC ConferenceSABCS 2022 TypePeer-reviewed article 1 February 2023 18:30